首页> 外国专利> COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOG, AT LEAST ONE IONIC SPECIES AND AN AMPHIPHILIC COMPOUND CONTAINING HYDROPHOBIC RADICALS

COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOG, AT LEAST ONE IONIC SPECIES AND AN AMPHIPHILIC COMPOUND CONTAINING HYDROPHOBIC RADICALS

机译:包含淀粉样蛋白,淀粉样蛋白受体激动剂或淀粉样蛋白类似物,至少一种离子物种和含疏水基团的两亲化合物的可注射水溶液形式的组合物

摘要

The invention relates to a composition in the form of an injectable solution, comprising: amylin, an amylin receptor agonist or an amylin analog; at least one ionic species; and an amphiphilic compound comprising a hydrophilic skeleton HB, substituted by at least one hydrophobic radical -Hy of formula (I). The invention further relates to a composition according to the invention, characterised in that it also comprises prandial insulin. In one embodiment, the composition also comprises GLP- 1, GLP-1 analogs, and GLP-1 receptor agonists, commonly called GLP-1 RA.
机译:本发明涉及可注射溶液形式的组合物,其包含:胰岛淀粉样多肽,胰岛淀粉样多肽受体激动剂或胰岛淀粉样多肽类似物;至少一种离子物质;以及包含被至少一个式(I)的疏水基-Hy取代的亲水骨架HB的两亲化合物。本发明进一步涉及根据本发明的组合物,其特征在于其还包含餐前胰岛素。在一个实施方案中,该组合物还包含GLP-1,GLP-1类似物和GLP-1受体激动剂,通常称为GLP-1RA。

著录项

  • 公开/公告号WO2020025826A1

    专利类型

  • 公开/公告日2020-02-06

    原文格式PDF

  • 申请/专利权人 ADOCIA;

    申请/专利号WO2019EP70954

  • 发明设计人 DAUTY EMMANUEL;

    申请日2019-08-03

  • 分类号A61K38/22;A61K38/28;A61K45/06;A61K47/30;A61P3/10;

  • 国家 WO

  • 入库时间 2022-08-21 11:13:37

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号